Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hollander

Showing results (131-140 of 246) with videos related to

Pageof 25
Sort By:
Comprehensive Psychiatry|June 29, 2010
Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorderLorrin M Koran, Daniel Bromberg, Carl S Hornfeldt, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 15, 2005
Imaging monetary reward in pathological gamblersEric Hollander, Stefano Pallanti, Nicolò Baldini Rossi, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 21, 2009
Familial associations of intense preoccupations, an empirical factor of the restricted, repetitive behaviors and interests domain of autismChristopher J Smith, Colleen M Lang, Lauren Kryzak, et al.
International Journal of Psychiatry in Clinical Practice|May 1, 2012
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary careBorwin Bandelow, Leo Sher, Robertas Bunevicius, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 12, 2023
Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorderRussell Tobe, Yajing Zhu, Teresa Gleissl, et al.
The American Journal of Psychiatry|July 4, 2006
Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disordersM Mehmet Haznedar, Monte S Buchsbaum, Erin A Hazlett, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 3, 2006
Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorderEric Hollander, Alicia Kaplan, James Schmeidler, et al.
Social Cognitive and Affective Neuroscience|December 1, 2010
Oxytocin can hinder trust and cooperation in borderline personality disorderJennifer Bartz, Daphne Simeon, Holly Hamilton, et al.
Journal of Child and Adolescent Psychopharmacology|October 31, 2006
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorderEric Hollander, Stacey Wasserman, Erika N Swanson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 24, 2002
Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disordersEric Hollander, Sherie Novotny, Margaret Hanratty, et al.
Pageof 25

Showing results (131-140 of 246) with videos related to

Sort By:
Pageof 25
Comprehensive Psychiatry|June 29, 2010
Extended-release fluvoxamine and improvements in quality of life in patients with obsessive-compulsive disorderLorrin M Koran, Daniel Bromberg, Carl S Hornfeldt, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|September 15, 2005
Imaging monetary reward in pathological gamblersEric Hollander, Stefano Pallanti, Nicolò Baldini Rossi, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|March 21, 2009
Familial associations of intense preoccupations, an empirical factor of the restricted, repetitive behaviors and interests domain of autismChristopher J Smith, Colleen M Lang, Lauren Kryzak, et al.
International Journal of Psychiatry in Clinical Practice|May 1, 2012
Guidelines for the pharmacological treatment of anxiety disorders, obsessive-compulsive disorder and posttraumatic stress disorder in primary careBorwin Bandelow, Leo Sher, Robertas Bunevicius, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|April 12, 2023
Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorderRussell Tobe, Yajing Zhu, Teresa Gleissl, et al.
The American Journal of Psychiatry|July 4, 2006
Volumetric analysis and three-dimensional glucose metabolic mapping of the striatum and thalamus in patients with autism spectrum disordersM Mehmet Haznedar, Monte S Buchsbaum, Erin A Hazlett, et al.
The Journal of Neuropsychiatry and Clinical Neurosciences|January 3, 2006
Neurological soft signs as predictors of treatment response to selective serotonin reuptake inhibitors in obsessive-compulsive disorderEric Hollander, Alicia Kaplan, James Schmeidler, et al.
Social Cognitive and Affective Neuroscience|December 1, 2010
Oxytocin can hinder trust and cooperation in borderline personality disorderJennifer Bartz, Daphne Simeon, Holly Hamilton, et al.
Journal of Child and Adolescent Psychopharmacology|October 31, 2006
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorderEric Hollander, Stacey Wasserman, Erika N Swanson, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 24, 2002
Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disordersEric Hollander, Sherie Novotny, Margaret Hanratty, et al.
Pageof 25